Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication

被引:25
作者
Honda, Kazutaka [1 ]
Zheng, Nan [1 ]
Murakoshi, Hayato [1 ]
Hashimoto, Masao [1 ]
Sakai, Keiko [1 ]
Borghan, Mohamed Ali [1 ,2 ]
Chikata, Takayuki [1 ]
Koyanagi, Madoka [1 ]
Tamura, Yoshiko [1 ]
Gatanaga, Hiroyuki [1 ,3 ]
Oka, Shinichi [1 ,3 ]
Takiguchi, Masafumi [1 ]
机构
[1] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan
[2] Univ Nizwa, Coll Arts & Sci, Dept Biol Sci, Nizwa, Oman
[3] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo, Japan
关键词
CTL; Escape mutation; Fitness; HLA-C; HIV infection; IMMUNODEFICIENCY-VIRUS TYPE-1; I DOWN-REGULATION; CELLULAR IMMUNE-RESPONSES; SURFACE EXPRESSION; PRIMARY INFECTION; VIRAL LOAD; NEF; ASSOCIATION; MUTATIONS; BINDING;
D O I
10.1002/eji.201040841
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 mutants escaping from HLA-A-or HLA-B-restricted CTL have been well studied, but those from HLA-C-restricted CTL have not. Therefore we investigated the ability of HLA-C-restricted CTL to select HIV-1 escape mutants. In the present study, we identified two novel HLA-Cw*1202-restricted Pol-specific CTL epitopes (Pol328-9 and Pol463-10). CTL specific for these epitopes were detected in 25-40% of chronically HIV-1-infected HLA-Cw*1202(+) 1 individuals and had strong abilities to kill HIV-1-infected cells and to suppress HIV-1 replication in vitro, suggesting that these CTL may have the ability to effectively control HIV-1 in some HLA-Cw*1202(+) individuals. Sequence analysis of these epitopes showed that a V-to-A substitution at the 9th position (V9A) of Pol 463-10 was significantly associated with the HLA-Cw*1202 allele and that the V9A mutant was slowly selected in the HLA-Cw*1202(+) individuals. Pol 463-10-specific CTL failed both to kill the V9A virus-infected cells and to suppress replication of the V9A mutant. These results indicate that the V9A mutation was selected as an escape mutant by the Pol463-10-specific CTL. The present study strongly suggests that some HLA-C-restricted CTL have a strong ability to suppress HIV-1 replication so that they can select HIV escape mutants as in the case of HLA-A-restricted or HLA-B-restricted CTL.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 43 条
[1]   Nef interference with HIV-1-specific CTL antiviral activity is epitope specific [J].
Adnan, Sama ;
Balamurugan, Arumugam ;
Trocha, Alicja ;
Bennett, Michael S. ;
Ng, Hwee L. ;
Ali, Ayub ;
Brander, Christian ;
Yang, Otto O. .
BLOOD, 2006, 108 (10) :3414-3419
[2]   Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation [J].
Akari, H ;
Arold, S ;
Fukumori, T ;
Okazaki, T ;
Strebel, K ;
Adachi, A .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2907-2912
[3]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[4]   HIV Nef:: Role in pathogenesis and viral fitness [J].
Arien, Kevin K. ;
Verhasselt, Bruno .
CURRENT HIV RESEARCH, 2008, 6 (03) :200-208
[5]   Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].
Barouch, DH ;
Kunstman, J ;
Kuroda, MJ ;
Schmitz, JE ;
Santra, S ;
Peyerl, FW ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Gorgone, DA ;
Montefiori, DC ;
Lewis, MG ;
Wolinsky, SM ;
Letvin, NL .
NATURE, 2002, 415 (6869) :335-339
[6]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[7]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[8]   The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells [J].
Cohen, GB ;
Gandhi, RT ;
Davis, DM ;
Mandelboim, O ;
Chen, BK ;
Strominger, JL ;
Baltimore, D .
IMMUNITY, 1999, 10 (06) :661-671
[9]   HLA-DEPENDENT VARIATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN ALTER PEPTIDE HLA BINDING [J].
COUILLIN, I ;
CONNAN, F ;
CULMANNPENCIOLELLI, B ;
GOMARD, E ;
GUILLET, JG ;
CHOPPIN, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) :728-732
[10]   Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach [J].
De Groot, AS ;
Jesdale, B ;
Martin, W ;
Saint Aubin, C ;
Sbai, H ;
Bosma, A ;
Lieberman, J ;
Skowron, G ;
Mansourati, F ;
Mayer, KH .
VACCINE, 2003, 21 (27-30) :4486-4504